Healthcare & Life Sciences
CombinatoRx
United States
acquiredacquired
acquired
Stage
About
CombinatoRx was a biopharmaceutical company founded in 2002 that developed novel synergistic combination pharmaceuticals targeting complex human diseases; it merged with Neuromed in 2009.
Explore CombinatoRx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.